Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Petry

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITOPhilipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancerMichael Untch, Volker Möbus, Walther Kuhn, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 29, 2015
S2k guideline* "Diagnosis and therapy of syphilis"--short versionHelmut Schöfer, Tobias Weberschock, Wolfgang Bräuninger, et al.
The Journal of Infectious Diseases|June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized TrialLi-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
American Journal of Obstetrics and Gynecology|January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study groupLinn Woelber, Katharina Prieske, Christine Eulenburg, et al.
International Journal of Cancer|August 28, 2007
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)Andreas M Kaufmann, John D Nieland, Ingrid Jochmus, et al.
American Journal of Preventive Medicine|December 28, 2020
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European CountriesClaudia Robles, Laia Bruni, Amelia Acera, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 29, 2011
Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITOPhilipp Harter, Jalid Sehouli, Alexander Reuss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Intensive dose-dense compared with conventionally scheduled preoperative chemotherapy for high-risk primary breast cancerMichael Untch, Volker Möbus, Walther Kuhn, et al.
Nature Reviews. Clinical Oncology|September 2, 2015
HPV-FASTER: broadening the scope for prevention of HPV-related cancerF Xavier Bosch, Claudia Robles, Mireia Díaz, et al.
International Journal of Cancer|September 30, 2020
Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter studyJesper Bonde, Arno Floore, Ditte Ejegod, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|April 29, 2015
S2k guideline* "Diagnosis and therapy of syphilis"--short versionHelmut Schöfer, Tobias Weberschock, Wolfgang Bräuninger, et al.
The Journal of Infectious Diseases|June 8, 2017
Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized TrialLi-Min Huang, Thanyawee Puthanakit, Chiu Cheng-Hsun, et al.
American Journal of Obstetrics and Gynecology|January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study groupLinn Woelber, Katharina Prieske, Christine Eulenburg, et al.
International Journal of Cancer|August 28, 2007
Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)Andreas M Kaufmann, John D Nieland, Ingrid Jochmus, et al.
American Journal of Preventive Medicine|December 28, 2020
Determinants of Human Papillomavirus Vaccine Uptake by Adult Women Attending Cervical Cancer Screening in 9 European CountriesClaudia Robles, Laia Bruni, Amelia Acera, et al.
International Journal of Cancer|June 25, 2020
Association of genomic variants at the human leukocyte antigen locus with cervical cancer risk, HPV status and gene expression levelsDhanya Ramachandran, Peter Schürmann, Qianqian Mao, et al.
Pageof 8